AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Return
13.43%
This Quarter Return
+2.35%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$14.9B
AUM Growth
+$373M
(+2.6%)
Cap. Flow
+$118M
Cap. Flow
% of AUM
0.79%
Top 10 Holdings %
Top 10 Hldgs %
56.71%
Holding
1,166
New
198
Increased
342
Reduced
449
Closed
173
Top Buys
| 1 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
$51M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$31.3M |
| 3 |
Merck
MRK
|
$25.7M |
| 4 |
LyondellBasell Industries
LYB
|
$24.8M |
| 5 |
Johnson & Johnson
JNJ
|
$21.4M |
Top Sells
| 1 |
Broadcom
AVGO
|
$34M |
| 2 |
JPMorgan Chase
JPM
|
$32M |
| 3 |
Verizon
VZ
|
$29.4M |
| 4 |
Cameco
CCJ
|
$28.6M |
| 5 |
MPLX
MPLX
|
$24M |
Sector Composition
| 1 | Energy | 66.41% |
| 2 | Technology | 4.66% |
| 3 | Financials | 3.55% |
| 4 | Consumer Discretionary | 3.47% |
| 5 | Healthcare | 3.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
Dr. Reddy's Laboratories
RDY
$11.9B
| $529K | ﹤0.01% |
33,310
-1,500
| -4% | -$23.8K |
|
602
Grupo Cibest S.A. American Depositary Shares (each representing four (4) Preferred Shares)
CIB
$12.5B
| $529K | ﹤0.01% |
16,844
+1,500
| +10% | +$47.1K |
|
603
Expedia Group
EXPE
$26.6B
| $528K | ﹤0.01% |
+3,564
| New | +$528K |
|
604
Veritex Holdings
VBTX
$1.87B
| $523K | ﹤0.01% |
19,866
-1,617
| -8% | -$42.6K |
|
605
Ethan Allen Interiors
ETD
$772M
| $521K | ﹤0.01% |
16,349
-1,005
| -6% | -$32K |
|
606
Tourmaline Bio
TRML
$687M
| $508K | ﹤0.01% |
19,773
-216
| -1% | -$5.55K |
|
607
Camden Property Trust
CPT
$11.9B
| $508K | ﹤0.01% |
4,115
-193
| -4% | -$23.8K |
|
608
Arcturus Therapeutics
ARCT
$485M
| $507K | ﹤0.01% |
21,838
-8,277
| -27% | -$192K |
|
609
iShares MSCI India ETF
INDA
$9.26B
| $499K | ﹤0.01% |
8,534
+2,405
| +39% | +$141K |
|
610
Fulgent Genetics
FLGT
$672M
| $499K | ﹤0.01% |
22,942
-420
| -2% | -$9.13K |
|
611
Valley National Bancorp
VLY
$6.01B
| $498K | ﹤0.01% |
54,952
-4,623
| -8% | -$41.9K |
|
612
JD.com
JD
$44.6B
| $496K | ﹤0.01% |
12,392
-1,788
| -13% | -$71.5K |
|
613
Invitation Homes
INVH
$18.5B
| $494K | ﹤0.01% |
13,997
-1,164
| -8% | -$41K |
|
614
Centrus Energy
LEU
$3.74B
| $491K | ﹤0.01% |
+8,950
| New | +$491K |
|
615
Allogene Therapeutics
ALLO
$255M
| $491K | ﹤0.01% |
175,285
+12,427
| +8% | +$34.8K |
|
616
Ironwood Pharmaceuticals
IRWD
$188M
| $484K | ﹤0.01% |
117,535
-6,440
| -5% | -$26.5K |
|
617
Greif Class B
GEF.B
$2.5B
| $471K | ﹤0.01% |
6,745
-515
| -7% | -$36K |
|
618
PPL Corp
PPL
$26.6B
| $471K | ﹤0.01% |
14,230
-5,660
| -28% | -$187K |
|
619
Constellation Energy
CEG
$94.2B
| $468K | ﹤0.01% |
+1,800
| New | +$468K |
|
620
Powell Industries
POWL
$3.24B
| $466K | ﹤0.01% |
2,097
-179
| -8% | -$39.7K |
|
621
Mineralys Therapeutics
MLYS
$2.7B
| $463K | ﹤0.01% |
38,264
-471
| -1% | -$5.7K |
|
622
Upbound Group
UPBD
$1.47B
| $453K | ﹤0.01% |
14,173
-1,221
| -8% | -$39.1K |
|
623
Y-mAbs Therapeutics
YMAB
$390M
| $450K | ﹤0.01% |
34,231
+7
| +0% | +$92 |
|
624
Celcuity
CELC
$2.36B
| $449K | ﹤0.01% |
30,093
+2,714
| +10% | +$40.5K |
|
625
ACM Research
ACMR
$1.76B
| $443K | ﹤0.01% |
21,847
+9,727
| +80% | +$197K |
|